EPHA2 and colorectal cancer: IGF2BP2 and IGF2BP3 enhanced the stability of methylated ephrin type-A receptor 2 (EPHA2) and vascular endothelial growth factor A (VEGFA) mRNAs, respectively, in colorectal cancer cells.